FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1217564004: Upadacitinib hemihydrate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Apr 2022. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
5036720011 Upadacitinib hemihydrate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
5036721010 Upadacitinib hemihydrate en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Upadacitinib hemihydrate Is a Heterocyclic compound true Inferred relationship Existential restriction modifier
Upadacitinib hemihydrate Is a Substance with Janus kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Upadacitinib hemihydrate Has disposition Janus kinase inhibitor true Inferred relationship Existential restriction modifier
Upadacitinib hemihydrate Is modification of Upadacitinib true Inferred relationship Existential restriction modifier
Upadacitinib hemihydrate Is a Immunosuppressant true Inferred relationship Existential restriction modifier
Upadacitinib hemihydrate Has disposition Immunomodulator true Inferred relationship Existential restriction modifier
Upadacitinib hemihydrate Is a Upadacitinib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Upadacitinib 45mg modified-release tablets Has specific active ingredient True Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
Upadacitinib 15mg modified-release tablets Has specific active ingredient True Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
Upadacitinib 30mg modified-release tablets Has specific active ingredient True Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
Rinvoq 30mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient True Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
Upadacitinib 15mg modified-release tablets 28 tablet Has specific active ingredient True Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
Rinvoq 15mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient True Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
Rinvoq 30mg modified-release tablets (AbbVie Ltd) Has specific active ingredient True Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has specific active ingredient True Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
Upadacitinib 30mg modified-release tablets 28 tablet Has specific active ingredient True Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
Rinvoq 45mg modified-release tablets (AbbVie Ltd) Has specific active ingredient True Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient True Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
Upadacitinib 45mg modified-release tablets 28 tablet Has specific active ingredient True Upadacitinib hemihydrate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start